These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9381271)

  • 1. [Follicular lymphomas].
    García-Conde J; Tormo M; Terol MJ; Benet I
    Sangre (Barc); 1997 Jun; 42(3):243-5. PubMed ID: 9381271
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follicular lymphoma, medium-sized cell type and mixed type].
    Ohno T; Ito M; Shiku H
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):235-9. PubMed ID: 9851127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Follicular lymphoma].
    Illés A; Krenács L; Borbényi Z
    Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience.
    López R; Martino R; Sureda A; Nomdedéu J; Briones J; Martin-Henao G; García J; Brunet S; Sierra J
    Haematologica; 1999 Apr; 84(4):350-5. PubMed ID: 10190950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma.
    Forrest DL; Thompson K; Nevill TJ; Couban S; Fernandez LA
    Bone Marrow Transplant; 2002 Jun; 29(12):973-8. PubMed ID: 12098065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
    Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
    Noriega MF; De Brasi C; Narbaitz M; Rodríguez A; Slavutsky I
    Pathology; 2010; 42(6):598-601. PubMed ID: 20854087
    [No Abstract]   [Full Text] [Related]  

  • 9. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
    Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M
    Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan.
    Fujimori Y; Saheki K; Yamada S; Yamada S; Mori A; Itoh T; Okada M; Takatsuka H; Wada H; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
    Int J Hematol; 1999 Oct; 70(3):207-8. PubMed ID: 10561916
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological bone marrow changes after reduced-intensity hematopoietic stem cell transplantation for follicular lymphoma involving bone marrow.
    Maeda T; Shiozawa E; Saito B; Usui T; Nakashima H; Hattori N; Adachi D; Yanagisawa K; Kawakami K; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H
    Pathol Int; 2007 Jun; 57(6):378-82. PubMed ID: 17539969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product support.
    Sefcick A; Byrne JL; Russell NH
    Bone Marrow Transplant; 2000 Nov; 26(10):1140-1. PubMed ID: 11108322
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation.
    Cairoli R; Grillo G; Tedeschi A; D'Avanzo G; Marenco P; Morra E
    Haematologica; 2004 Mar; 89(3):361-3. PubMed ID: 15020279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 evaluation in patients in long-term complete remission after bone marrow transplantation.
    Colombat P; Garrigue MA; Lamagnere JP; Muh JP; Linassier C
    J Clin Oncol; 1994 Nov; 12(11):2516. PubMed ID: 7964969
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E; Fernández de Sevilla A; Domingo-Claros A; Romagosa V; Martín-Henao GA; De Sanjose S; Carmona M; Petit J; García J; Grañena A
    Bone Marrow Transplant; 2000 Nov; 26(10):1051-6. PubMed ID: 11108302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
    Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
    Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.